A metagene of NRF2 expression is a prognostic biomarker in all stage colorectal cancer (2019)

First Author: O'Cathail S

Attributed to: Understanding how an MLH1 promoter polymorphism predisposes to colorectal cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/690974

Publication URI: http://dx.doi.org/10.1101/690974

Type: Preprint